Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)

The prototype ORACLE scale based on two simple measures of type 2 airway inflammation (blood eosinophils and F(ENO)) quantifies the excess risk conferred by raised biomarkers that is removed by type-2 anti-inflammatory treatment in trial populations https://bit.ly/3F1gnUl

Detalles Bibliográficos
Autores principales: Couillard, Simon, Do, William Il Hoon, Beasley, Richard, Hinks, Timothy S.C., Pavord, Ian D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819242/
https://www.ncbi.nlm.nih.gov/pubmed/35141315
http://dx.doi.org/10.1183/23120541.00570-2021
_version_ 1784646016035717120
author Couillard, Simon
Do, William Il Hoon
Beasley, Richard
Hinks, Timothy S.C.
Pavord, Ian D.
author_facet Couillard, Simon
Do, William Il Hoon
Beasley, Richard
Hinks, Timothy S.C.
Pavord, Ian D.
author_sort Couillard, Simon
collection PubMed
description The prototype ORACLE scale based on two simple measures of type 2 airway inflammation (blood eosinophils and F(ENO)) quantifies the excess risk conferred by raised biomarkers that is removed by type-2 anti-inflammatory treatment in trial populations https://bit.ly/3F1gnUl
format Online
Article
Text
id pubmed-8819242
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-88192422022-02-08 Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE) Couillard, Simon Do, William Il Hoon Beasley, Richard Hinks, Timothy S.C. Pavord, Ian D. ERJ Open Res Research Letter The prototype ORACLE scale based on two simple measures of type 2 airway inflammation (blood eosinophils and F(ENO)) quantifies the excess risk conferred by raised biomarkers that is removed by type-2 anti-inflammatory treatment in trial populations https://bit.ly/3F1gnUl European Respiratory Society 2021-02-07 /pmc/articles/PMC8819242/ /pubmed/35141315 http://dx.doi.org/10.1183/23120541.00570-2021 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by/4.0/This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
spellingShingle Research Letter
Couillard, Simon
Do, William Il Hoon
Beasley, Richard
Hinks, Timothy S.C.
Pavord, Ian D.
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)
title Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)
title_full Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)
title_fullStr Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)
title_full_unstemmed Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)
title_short Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)
title_sort predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype oxford asthma attack risk scale (oracle)
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819242/
https://www.ncbi.nlm.nih.gov/pubmed/35141315
http://dx.doi.org/10.1183/23120541.00570-2021
work_keys_str_mv AT couillardsimon predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle
AT dowilliamilhoon predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle
AT beasleyrichard predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle
AT hinkstimothysc predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle
AT pavordiand predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle

Ejemplares similares